177 related articles for article (PubMed ID: 35888632)
1. The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry.
Cordeanu EM; Jambert L; Tousch J; Mirea C; Delatte A; Younes W; Woehl B; Harter C; Frantz AS; Hamade A; Schini-Kerth V; Ohlmann P; Andres E; Stephan D
Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888632
[TBL] [Abstract][Full Text] [Related]
2. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
3. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
4. [Screening for occult cancer in patients with unprovoked venous thromboembolism].
Qiao LS; Xu XM
Zhonghua Jie He He Hu Xi Za Zhi; 2023 May; 46(5):498-502. PubMed ID: 37147813
[TBL] [Abstract][Full Text] [Related]
5. Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry.
Gaertner S; Cordeanu EM; Mirea C; Frantz AS; Auger C; Bilbault P; Ohlmann P; Schini-Kerth V; Stephan D
Int J Cardiol; 2018 Feb; 252():169-174. PubMed ID: 29169908
[TBL] [Abstract][Full Text] [Related]
6. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
7. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Broderick C; Yeoh SE; Stansby G
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414
[TBL] [Abstract][Full Text] [Related]
8. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
[TBL] [Abstract][Full Text] [Related]
9. Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism.
Han D; ó Hartaigh B; Lee JH; Cho IJ; Shim CY; Chang HJ; Hong GR; Ha JW; Chung N
PLoS One; 2016; 11(4):e0153514. PubMed ID: 27073982
[TBL] [Abstract][Full Text] [Related]
10. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
[TBL] [Abstract][Full Text] [Related]
11. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
12. Occult cancer-related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism.
Gran OV; Braekkan SK; Paulsen B; Skille H; Rosendaal FR; Hansen JB
J Thromb Haemost; 2017 Jul; 15(7):1361-1367. PubMed ID: 28440069
[TBL] [Abstract][Full Text] [Related]
13. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2015 Mar; (3):CD010837. PubMed ID: 25749503
[TBL] [Abstract][Full Text] [Related]
14. Utility of additional abdominopelvic CT in detecting occult cancer in patients with unprovoked venous thromboembolism.
Vaidyanathan S; Walsh J; Cliffe H; Saleem N; Weston MJ; Lowe AS; Chowdhury FU
Clin Radiol; 2016 Jun; 71(6):501-6. PubMed ID: 27005017
[TBL] [Abstract][Full Text] [Related]
15. Revisiting occult cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Carrier M
Thromb Res; 2018 Apr; 164 Suppl 1():S7-S11. PubMed ID: 29703487
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
Chauchard M; Benali K; Papo T; Sacre K
Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
[TBL] [Abstract][Full Text] [Related]
17. Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.
Jara-Palomares L; van Es N; Praena-Fernandez JM; Le Gal G; Otten HM; Robin P; Piccioli A; Lecumberri R; Religa P; Rieu V; Rondina M; Beckers M; Prandoni P; Salaun PY; Di Nisio M; Bossuyt PM; Kraaijpoel N; Büller HR; Carrier M
Thromb Res; 2019 Apr; 176():79-84. PubMed ID: 30780008
[TBL] [Abstract][Full Text] [Related]
18. Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions.
Patel SS; Tao D; McMurry HS; Shatzel JJ
Eur J Haematol; 2023 Jan; 110(1):24-31. PubMed ID: 36192850
[TBL] [Abstract][Full Text] [Related]
19. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Ihaddadene R; Corsi DJ; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Le Gal G; Carrier M
Blood; 2016 Apr; 127(16):2035-7. PubMed ID: 26817957
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study.
Cohen AT; Katholing A; Rietbrock S; Bamber L; Martinez C
Thromb Haemost; 2017 Jan; 117(1):57-65. PubMed ID: 27709226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
